# US 2021/0009505 A1 · Cationic lipids and transfection methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0009505 A1
- Document ID: US20210009505A1
- Status: Published application
- Kind: A1
- Application number: 16/920,556
- Filed: 2020-07-03
- Published: 2021-01-14
- Earliest claimed: 2019-07-03
- Assignees: Factor Bioscience Inc.
- Applicants: Factor Bioscience Inc.
- Inventors: Matthew ANGEL; Franklin Kostas; Christopher Rohde
- Web page: https://patentgrep.com/patent/US20210009505A1

## CPC

- C07C 215/24: and acyclic
- A61K 9/0021: {Intradermal administration, e.g. through microneedle arrays or needleless injectors}
- A61K 9/10: Dispersions; Emulsions
- A61K 9/1272: comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents {A61K47/543})
- A61K 47/543: {Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine}
- C07C 215/18: with hydroxy groups and at least two amino groups bound to the carbon skeleton
- C12N 15/88: using microencapsulation, e.g. using {amphiphile} liposome vesicle
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates in part to novel cationic lipids and their use, e.g., in delivering nucleic acids to cells.

## Claims

### Claim 1

A compound of Formula (IV)
wherein n is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15.

### Claim 2 (depends on 1)

The compound of claim 1, wherein n is 2-15.

### Claim 3 (depends on 1)

The compound of claim 1, wherein n is 2-12.

### Claim 4 (depends on 1)

The compound of claim 1, wherein the compound is:

### Claim 5 (depends on 1)

The compound of claim 1, wherein the compound is:

### Claim 6 (depends on 1)

The compound of claim 1, wherein the compound is:

### Claim 7 (depends on 1)

The compound of claim 1, wherein the compound is:

### Claim 8 (depends on 1)

The compound of claim 1, wherein the compound is:

### Claim 9 (depends on 1)

The compound of claim 1, wherein the compound is:

### Claim 10 (depends on 1)

The compound of claim 1, wherein the compound is:

### Claim 11 (depends on 1)

The compound of claim 1, wherein the compound is:

### Claim 12 (depends on 1)

A pharmaceutical composition comprising a compound of claim 1, and a pharmaceutically acceptable carrier or excipient.

### Claim 13 (depends on 1)

A lipid aggregate comprising the compound of claim 1.

### Claim 14 (depends on 13)

The lipid aggregate of claim 13, wherein the lipid aggregate does not comprise one or more additional lipids or polymers.

### Claim 15 (depends on 13)

The lipid aggregate of claim 13, further comprising a nucleic acid, selected from a DNA or RNA molecule.

### Claim 16

A method for transfecting a cell with a nucleic acid, comprising contacting the cell with a complex of the nucleic acid and a compound of Formula (IV):
wherein n is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15.

### Claim 17 (depends on 16)

The method of claim 16, wherein the compound is selected from:
